Skip to content

Boston Trust Walden Corp: ABBV position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Boston Trust Walden Corp on ABBV, newest first. How the timeline and the estimate are built.

Boston Trust Walden Corp held 4,810,375 ABBV shares at 2026-06-30 per its 13F-HR filed 2026-08-04.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 4,810,375 shares
    Change vs previous 13F +1,350,439 shares

    0.96% of the 13F portfolio, value $1,209,075,851.

    13F-HR 0001386060-26-000035 filed by Boston Partners
    Filed (acceptance time not in the bulk data set), ingested

    • Boston Partners: 4,784,316 shares
    • Boston Trust Walden Corp: 26,059 shares

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 3,459,936 shares
    Change vs previous 13F +33,989 shares

    0.7% of the 13F portfolio, value $751,726,854.

    13F-HR 0001386060-26-000017 filed by Boston Partners
    Filed (acceptance time not in the bulk data set), ingested

    • Boston Partners: 3,434,210 shares
    • Boston Trust Walden Corp: 25,726 shares

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 3,425,947 shares
    Change vs previous 13F -413,867 shares

    0.71% of the 13F portfolio, value $781,801,568.

    13F-HR 0001386060-26-000014 filed by Boston Partners
    Filed (acceptance time not in the bulk data set), ingested

    • Boston Partners: 3,400,221 shares
    • Boston Trust Walden Corp: 25,726 shares

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 3,839,814 shares
    Change vs previous 13F -1,138,662 shares

    0.8% of the 13F portfolio, value $888,940,981.

    13F-HR 0001386060-25-000020 filed by Boston Partners
    Filed (acceptance time not in the bulk data set), ingested

    • Boston Partners: 3,814,088 shares
    • Boston Trust Walden Corp: 25,726 shares

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F/A 4,978,476 shares
    Change vs previous 13F -1,392,620 shares

    0.89% of the 13F portfolio, value $926,633,648.

    13F-HR/A 0001085146-25-004915 filed by Boston Partners
    Filed (acceptance time not in the bulk data set), ingested

    • Boston Partners: 4,952,798 shares
    • Boston Trust Walden Corp: 25,678 shares

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2025-03-31
    13F 6,371,096 shares
    Change vs previous 13F +658,019 shares

    1.38% of the 13F portfolio, value $1,326,022,265.

    13F-HR 0001085146-25-002987 filed by Boston Partners
    Filed (acceptance time not in the bulk data set), ingested

    • Boston Partners: 6,345,296 shares
    • Boston Trust Walden Corp: 25,800 shares

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2024-12-31
    13F 5,713,077 shares
    Change vs previous 13F +1,503,440 shares

    1.05% of the 13F portfolio, value $1,013,417,058.

    13F-HR 0001085146-25-000961 filed by Boston Partners
    Filed (acceptance time not in the bulk data set), ingested

    • Boston Partners: 5,687,472 shares
    • Boston Trust Walden Corp: 25,605 shares

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2024-09-30
    13F 4,209,637 shares
    Change vs previous 13F not available

    0.84% of the 13F portfolio, value $829,905,702.

    13F-HR 0001085146-24-005518 filed by Boston Partners
    Filed (acceptance time not in the bulk data set), ingested

    • Boston Partners: 4,183,597 shares
    • Boston Trust Walden Corp: 26,040 shares

    Acceptance time not in the bulk data set (spec §4.2).